A phase 1-2 study of the type I progesterone receptor (PR) antagonist onapristone (ONA) in patients (pts) with advanced castration-resistant prostate cancer (CRPC). This is an ASCO Meeting Abstract ...
The NFκB pathway as a key mediator of the glioblastoma mesenchymal subtype in glioblastoma stem cells and human tumors. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する